M1 Kliniken AG/€M12
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About M1 Kliniken AG
M1 Kliniken AG, headquartered in Berlin, Germany, specializes in aesthetic medicine and plastic surgery services. Operating under the "M1 Med Beauty" brand, the company offers treatments such as breast augmentation, eyelid lifts, liposuction, and non-invasive procedures like hyaluronic acid and botulinum toxin injections. As of 2023, M1 Kliniken operates 58 specialist centers across ten countries, including Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. The company also manages the M1 Schlossklinik in Berlin, a facility with six operating theaters and 35 beds. M1 Kliniken's strategic focus on specialization and centralized purchasing enables it to offer high-quality medical services at competitive prices.
Ticker
€M12
Sector
Primary listing
XETRA
Employees
199
Headquarters
Website
M1 Kliniken AG Metrics
BasicAdvanced
€253M
15.99
€0.85
0.85
€0.50
3.67%
Price and volume
Market cap
€253M
Beta
0.85
52-week high
€18.65
52-week low
€12.82
Average daily volume
4.2K
Dividend rate
€0.50
Financial strength
Current ratio
1.91
Quick ratio
1.016
Long term debt to equity
5.427
Total debt to equity
15.735
Dividend payout ratio (TTM)
58.12%
Interest coverage (TTM)
13.52%
Profitability
EBITDA (TTM)
27.449
Gross margin (TTM)
12.80%
Net profit margin (TTM)
4.72%
Operating margin (TTM)
7.68%
Effective tax rate (TTM)
32.35%
Revenue per employee (TTM)
€1,700,000
Management effectiveness
Return on assets (TTM)
8.12%
Return on equity (TTM)
12.83%
Valuation
Price to earnings (TTM)
15.99
Price to revenue (TTM)
0.755
Price to book
2.43
Price to tangible book (TTM)
13.43
Price to free cash flow (TTM)
8.668
Free cash flow yield (TTM)
11.54%
Free cash flow per share (TTM)
1.574
Dividend yield (TTM)
3.67%
Forward dividend yield
3.67%
Growth
Revenue change (TTM)
7.23%
Earnings per share change (TTM)
58.79%
3-year revenue growth (CAGR)
2.54%
10-year revenue growth (CAGR)
30.87%
3-year earnings per share growth (CAGR)
21.19%
10-year earnings per share growth (CAGR)
10.81%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for M1 Kliniken AG stock?
M1 Kliniken AG (M12) has a market cap of €253M as of August 22, 2025.
What is the P/E ratio for M1 Kliniken AG stock?
The price to earnings (P/E) ratio for M1 Kliniken AG (M12) stock is 15.99 as of August 22, 2025.
Does M1 Kliniken AG stock pay dividends?
Yes, the M1 Kliniken AG (M12) stock pays dividends to shareholders. As of August 22, 2025, the dividend rate is €0.5 and the yield is 3.67%. M1 Kliniken AG has a payout ratio of 58.12% on a trailing twelve-month basis.
When is the next M1 Kliniken AG dividend payment date?
The next M1 Kliniken AG (M12) dividend payment date is unconfirmed.
What is the beta indicator for M1 Kliniken AG?
M1 Kliniken AG (M12) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.